Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,871
Total Claims
$1.5M
Drug Cost
668
Beneficiaries
$2,242
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-12%
Opioid rate vs peers
2.3% vs 2.6% avg
+110%
Cost per patient vs peers
$2,242 vs $1,068 avg
+59%
Brand preference vs peers
14.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
224
Opioid Claims
$4,882
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,388 claims · $1.3M
Generic: 8,330 claims · $181K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 167 | $256K |
| Sitagliptin Phosphate | 100 | $149K |
| Linagliptin | 81 | $109K |
| Empagliflozin/Linagliptin | 55 | $90K |
| Dapagliflozin Propanediol | 43 | $67K |
| Apixaban | 41 | $60K |
| Dulaglutide | 31 | $53K |
| Insulin Glargine,hum.Rec.Anlog | 98 | $51K |
| Sitagliptin Phos/Metformin Hcl | 34 | $45K |
| Linaclotide | 32 | $44K |
| Insulin Glargine,hum.Rec.Anlog | 49 | $43K |
| Fluticasone/Vilanterol | 47 | $42K |
| Sacubitril/Valsartan | 13 | $25K |
| Insulin Detemir | 26 | $24K |
| Rivaroxaban | 11 | $11K |
Prescribing Profile
Patient Profile
71
Avg Age
52%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About